Skip to content

Author

R. Wijdeven

We have 2 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

CRISPR activation screen uncovers MARCKSL1 as a gauge for extracellular vesicle secretion.

Extracellular vesicles (EVs) are central mediators of intercellular communication that originate from diverse membrane reservoirs. EV biogenesis can occur via multiple pathways, including outward budding of the plasma membrane (PM) and fusion of mature endosomes with the PM. The present study investigates how cells balance these competing routes using a genome-wide CRISPR activation screen for factors that alter surface expression of CD63-an EV-associated tetraspanin that shuttles between the PM and endosomes. This unbiased strategy identifies the membrane adaptor MARCKSL1 known to be upregulated across diverse tumor types. Overexpression of MARCKSL1 elevates CD63 abundance at the PM and boosts EV secretion. Proximity-based proteomics implicates the cytoskeleton-PM linker Radixin and the SNARE-associated protein STXBP3 as MARCKSL1 binding partners that respectively promote either PM-derived or endosome-derived EV secretion. Collectively, our findings reveal new insights into PM remodeling and position MARCKSL1 as a gauge between distinct EV biogenesis platforms.

Yingjie Zhong, Anna E. George, Roman I. Koning et al. · 0 citations
Open access Aug 2026

Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin

A genome-wide CRISPR screen to identify factors regulating sensitivity of cells to aclarubicin and identified p53 as a critical factor for cellular sensitivity suggests p53 could be an important factor to stratify patients for treatment with Aclarubicin.

Sabina Y. van der Zanden, Koen Schipper, Merle A. van Gelder et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.